Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Taro Pharm Inds (TARO)

Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Taro Pharm Inds 14 Hakitor Street Haifa Bay L3 10532 ISR

www.taro.com P: 914-345-9000

Description:

Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.

Key Statistics

Overview:

Market Capitalization, $K 1,586,172
Enterprise Value, $K 1,311,692
Shares Outstanding, K 37,587
Annual Sales, $ 572,950 K
Annual Net Income, $ 25,450 K
Last Quarter Sales, $ 157,150 K
Last Quarter Net Income, $ 20,210 K
EBIT, $ 21,970 K
EBITDA, $ 62,270 K
60-Month Beta 0.61
% of Insider Shareholders 13.80%
% of Institutional Shareholders 91.40%
Float, K 32,400
% Float 86.20%
Short Volume Ratio 0.58

Growth:

1-Year Return 72.54%
3-Year Return -42.99%
5-Year Return -60.72%
5-Year Revenue Growth -13.44%
5-Year Earnings Growth -89.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.56 on 01/25/24
Latest Earnings Date 05/28/24
Earnings Per Share ttm 1.52
EPS Growth vs. Prev Qtr 47.37%
EPS Growth vs. Prev Year 194.74%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TARO Ratios

Ratio
Price/Earnings ttm 27.78
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 3.26%
Return-on-Assets % 2.67%
Profit Margin % 4.44%
Debt/Equity 0.00
Price/Sales 2.60
Price/Cash Flow 24.16
Price/Book 0.89
Book Value/Share 47.33
Interest Coverage -1.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar